Revelation Biosciences In...
0.01
-0.00 (-20.63%)
At close: Jan 14, 2025, 3:50 PM
0.01
4.35%
After-hours Jan 14, 2025, 03:50 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 25.05K 40.01K 69.17K n/a n/a
Gross Profit -25.05K -40.01K -69.17K n/a n/a
Operating Income -8.66M -10.86M -11.95M -145.49K -3.64K
Interest Income n/a n/a n/a 10.91K n/a
Pretax Income -120.25K -10.83M -11.99M -1.63M -3.64K
Net Income -120.25K -10.79M -11.99M -1.63M -3.64K
Selling & General & Admin 4.51M 5.49M 5.04M 145.49K 3.64K
Research & Development 4.15M 5.38M 6.91M 2.56M n/a
Other Expenses n/a 34.96K -36.35K n/a n/a
Operating Expenses 8.66M 10.86M 11.95M 145.49K 3.64K
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a 144.26K n/a
Cost & Expenses 8.66M 10.86M 11.95M 145.49K 3.64K
Income Tax n/a -34.96K -219.78K -3.80K -171.86K
Shares Outstanding (Basic) 228.00K 17.97K 9.40K 8.66K 8.66K
Shares Outstanding (Diluted) 228.64K 17.97K 9.40K 8.66K 8.66K
EPS (Basic) -0.53 -600.77 -1.28K -188.18 -0.42
EPS (Diluted) -0.53 -600.77 -1.28K -188.18 -0.42
EBITDA -95.21K -10.84M -11.93M -145.49K -3.64K
Depreciation & Amortization 25.05K 40.01K 69.17K 3.80M 171.86K